Levalbuterol purified data

SEPR announced results of its double-blind, placebo-controlled, crossover dose finding trial of levalbuterol

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE